Dept of Pediatrics and Physiology. University of Nijmegen. Nijmegen, the Netherlands. Repeated opening of the bypass bridge during extracorporeal membrane oxygenation (ECMO) is necessary t o prevent clot formation. Using near infrared spectrophotomeuy concentration changes of oxyhemoglobin (AcO,Hb), deoxyhemoglobin (AcHHb) and total hemoglobin (AclHb) i n cerebral tissue were measured during a 10 s opening of the bypass bridge during ECMO i n 12 anesthetized piglets. Ac0,Hb and AcHHb reflect changes i n cerebral 0 , supply, while ActHb reflects changes i n cerebral blood volume (CBV).
Simultaneously heart rate (HR). arterial 0, saturation (saO,), mean arterial blood pressure (MABP). central venous pressure (CVP). intracranial pressure (ICP) and mean blood flow i n left common carotid artery (CaBF) were also continuously measured. Most variables showed biphasic changes. The peak values are shown i n table (*=p<0.05). HR and saO, were unchanged. Conclusion: opening of the bypass bridge results initially i n decreased CaBF, CBV and cerebral 0, supply which i s coliipensated by increased cerebral 0, extraction and vasodilatation, resulting i n secondary increased CBV and ICP. The increased CVP 111igIlt be caused by retrograde bloodflow thmugh the vcnous cannula. Repeated opening of the bypass bridge during ECMO might conrribule l o cercbrnl hemorrhage.
AMABP (mm Hg) -41.09f 13.14' 5.1 lf3.78* A C W (111111 Hg) 3.65f 1.30* -0.05t0.15 AICP (mm Hg) -1.32f 1.32' 4.79f3.17' ACaBF (n~Llnlin) -43.72f18.48* 8.93f5.55' Ac0,Hb (p11101/100 g) -0.73f 0.29* 0.18f0.12* AcHHb (pnioV100 g) 0.53f 0.21* -0.13f0.10* ActHb (plno11100 g) -0.293: 0.12* 0.17i0.07' RELATIONSHIP OF XANTHINE OXIDASE (XO) ACTIVITY TO IMMUNOREACTIVE ENZYME PROTEIN IN DEVELOPING HUMAN LIVER AND INTESTINE. Nina M. Linder, Annikki Sarnesto, and Kari 0. Raivio Children's Hospital, University of Helsinki, Finland XO is a major source of superoxide radicals and hydrogen peroxide, and has been ascribed a role in perinatal ischemia-reperfusion injury. We have previously shown that XO activity increases in the liver but decreases in the intestine during human fetal development. Since reversibly inactive forms as well as endogenous inhibitors of XO are known, our aim was to compare XO activities with immunoreactive XO protein levels in these two organs. XO was purified to apparent homogeneity from human milk. Antibodies to XO were raised in rabbits, purified by adsorption with human IgG and lactoferrin, and used in a sandwich-ELISA assay for XO protein (detection limit 10 ng/mg total protein). In fetal samples (10-40 weeks gestation), XO activities, measured with 14C-hypoxanthine as substrate, were linearly correlated with the XO protein concentrations in the same samples (r=0.74 for liver, r=0.91 for intestine). The slopes of the regression lines were not significantly different for liver and intestine. The constant specific activity (3~mol/min/mg XO protein) in both organs throughout gestation suggests that negligible amounts of inactive XO protein are present.
TRIGGER DELAY IN INFANT VENTILATORS
Arunas Liubsys, Torgny Norsted, Anders Jonzon, Gunnar Sedin. Departments of Pediatrics and Physiology and Medical Biophysics, Uppsala University, Uppsala, Sweden, and Neonatal Clinic, Vilnius University Children-s Hospital, Vilnius, Lithuania. With new technology it is possible to achieve patient triggered ventilation also in very preterm infants. To avoid accidental high transpulmonary pressures, the time between the start of spontaneous inspiration and ventilator insufflation (trigger delay time) has to be short. AIM: To determine the trigger delay time of three infant ventila-tors. METHODS: The Infant Star ventilator was equipped with an abdominal sensor and V.I.P.Bird and Babylog 8000 with flow sensors close to the proximal end of the endotracheal tube. To get a precise measurement of delay time we recorded phrenic nerve activity and airway pressure in anaesthetized cats and measured the time from the start of phrenic nerve activity to the increase in airway pressure caused by the ventilator. RESULTS: The shortest delay times were found at the highest sensitivity and during SIMV mode of operation. Trigger Inclusion criteria were: absence of fluoroangiographic signs of diabetic retinopathy, age>lO years, duration of disease>5 years, albumin excretion rate<20 mcg/min. At the beginning of the study all subjects underwent fluoroangio-graphy, monocular colour vision examination (Farnsworth 100 HUE) and glycated haemoglobin. After 4 years the same study protocol has been performed. During the follow-up 18 patients (group A) showed poor metabolic control (mean HbAlc 12.2%) and 22 patients (group B) had good metabolic control (mean HbAlc 8.1%). Colour vision examination as Total Error Score (TES) at the beginning of the study was 63.95(+40.17)in the group B and 68.60(+37.05) in the group A. After 4 years TES was 57.67(+34.56) in group B and 85.67(+42.95) in group A. In patients with HbAlc>9% we observed a significant worsening of chromatic sense(p=O.005) at the end of follow-up. Our study suggests that poor metabolic control can be a risk factor for the impairment of colour vision. C, 11.9+3.7mgll herapeutic levels were reached in I I lnfanis (73%) and remmed h~gh for more than 8 hours UI il~dividual infants. There appeared t o be good analgesia even a t levels bclow 10 mgll. Due t o long T,, values for TI, were not reliable.Over 80 % was excreted i n urine as APAP-sulfate. W e conclude that 1) APAP i n preterlns appears r o be safe and effective, 2) a higher dose might be needed t o shorten T, interval, and 3) dose interval should he more than 8 hours i n case of multiple doses.
T, 240 min T, 90 min(30-360) 
